Cellebrite DI Ltd NASDAQ NMS - GLOBAL MARKET:CLBT
The leadership team, board of directors, and 10% beneficial owners of Cellebrite DI Ltd, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
Armon Ronnen
—277,844 sharesBarter David
—375,953 sharesBaudot-Trajtenberg Nadine
—35,554 sharesCAPELLAS MICHAEL D
—17,804 sharesCLAMMER ADAM
—13,861,007 sharesDomnitz Yonatan
—60,795 sharesGEE DAVID NICHOLAS
—147,933 sharesGruber Dafna
—27,919 sharesHogan Thomas E.
—693,965 sharesJewell Marcus
—453,142 sharesRichardson Troy
—20,974 sharesShavit Sigalit
—82,738 sharesTadmor-Eilat Zohar
—129,814 sharesUtsumi Ryusuke
—40,795 sharesVan Buren Brandon
—35,554 sharesWade Christopher Michael
—610,453 sharesWindham Holly B.
—95,328 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.